Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT06330467
Eligibility Criteria:
I - Inclusion Criteria:
I-1: For all groups:
* Male or female
* Age \> or = 18
* Enrolled in or benefiting from a social security scheme
* Patient fluent in French
* Patient willing to undergo a psychological evaluation between 1h30 and 3h30
* Patient with a known history of psychotrauma in childhood before the age of 18 (sexual abuse, mistreatment, school harassment, natural disasters, attacks, etc.).
* Patient having received and understood complete information on the organization of the research and having given written free and informed consent prior to participation in the study.
I-2 : Patients in the borderline group
* Patients with main diagnosis of emotionally labile personality
* Patients with at least one psychiatric hospitalization in the last 3 years
I-3 : Patients in the early psychosis group
Patient with a diagnosis of mental state at risk of psychosis according to the criteria defined by CAARMS (Comprehensive Assessment of At Risk Mental State) OR Patients diagnosed with a first psychotic episode on an outpatient basis or following a hospital stay
I-4 : Patients in the functional dissociative crises group
Patients diagnosed with functional dissociative crises by a specialized epileptologist
II- Non-inclusion criteria
* Impairment of the subject making it difficult or not impossible to participate in the trial or to understand the information provided to him/her
* Patients with specific difficulties in understanding SCID-D questions
* Psychiatric condition requiring hospitalization
* Patients with symptoms of recent toxic consumption (alcohol, cannabis, other ...) disrupting assessment responses
* Patient taking part in a pharmacological study involving a pro-dissociative molecule of the psychedelic type
* Pregnant, parturient or nursing mothers
* Person deprived of liberty by judicial or administrative decision
* Person in a life-threatening emergency
* An adult under legal protection (guardianship, curatorship, safeguard of justice)
* Person unable to give consent and not subject to a legal protection measure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06330467
Study Brief:
Protocol Section:
NCT06330467